Chromosomal microarray analysis as the first-tier test for the identification of pathogenic copy number variants in chromosome 9 pericentric regions and its challenge

Chromosomal microarray analysis (CMA) has been recommended and practiced routinely in the large reference laboratories of U.S.A. as the first-tier test for the postnatal evaluation of individuals with intellectual disability, autism spectrum disorders, and/or multiple congenital anomalies. Using CMA...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Jia-Chi, Boyar, Fatih Z.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Letter to Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4980801/
https://www.ncbi.nlm.nih.gov/pubmed/27516809
http://dx.doi.org/10.1186/s13039-016-0272-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4980801/
https://www.ncbi.nlm.nih.gov/pubmed/27516809
http://dx.doi.org/10.1186/s13039-016-0272-6

Ejemplares similares